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ABSTRACT
Death domain–associated protein (Daxx) cooperates
with X-linked a-thalassaemia retardation syndrome
protein (ATRX), a putative member of the sucrose
non-fermentable 2 family of ATP-dependent
chromatin-remodelling proteins, acting as the core
ATPase subunit in this complex, whereas Daxx is
the targeting factor, leading to histone deacetylase
recruitment, H3.3 deposition and transcriptional re-
pression of cellular promoters. Despite recent
findings on the fundamental importance of chromatin
modification in host-cell gene regulation, it remains
unclear whether adenovirus type 5 (Ad5) transcrip-
tion is regulated by cellular chromatin remodelling
to allow efficient virus gene expression. Here, we
focus on the repressive role of the Daxx/ATRX
complex during Ad5 replication, which depends on
intact protein–protein interaction, as negative regu-
lation could be relieved with a Daxx mutant that is
unable to interact with ATRX. To ensure efficient viral
replication, Ad5 E1B-55K protein inhibits Daxx and
targets ATRX for proteasomal degradation in co-
operation with early region 4 open reading frame
protein 6 and cellular components of a cullin-
dependent E3-ubiquitin ligase. Our studies illustrate
the importance and diversity of viral factors antago-
nizing Daxx/ATRX-mediated repression of viral gene
expression and shed new light on the modulation of
cellular chromatin remodelling factors by Ad5. We
show for the first time that cellular Daxx/ATRX chro-
matin remodelling complexes play essential roles in
Ad gene expression and illustrate the importance of
early viral proteins to counteract cellular chromatin
remodelling.
INTRODUCTION
For >50 years, adenovirus biology has mainly focused on
virus/host interactions and has established that manipula-
tion of host cell homeostasis is required for efficient infec-
tion. Despite recent findings on the fundamental
importance of chromatin status in host-cell gene regula-
tion, it remains unclear whether adenovirus (Ad) tran-
scription is subject to cellular chromatin remodelling.
Recent reports demonstrated that Ad DNA is present in
a tightly condensed state in the nucleocapsid, arguing for
the requirement of altering chromatin modification early
in infection to allow efficient virus gene expression.
We and others reported previously that the transcrip-
tional repressor ‘death domain–associated protein’ (Daxx)
is a principal component of ‘promyelocytic leukemia
protein (PML) nuclear bodies’ (PML-NBs) and a
negative regulator of Ad5 replication during productive
infection (1,2). Daxx is mainly found in the nucleus,
associated to PML-NBs, or at heterochromatin areas in
a complex with ‘X-linked a-thalassaemia retardation
syndrome protein’ (ATRX) (3–5). PML-NB association
of Daxx was found to alleviate gene repression and
activate apoptosis, whereas chromatin-bound Daxx acts
in a transcriptionally repressive manner [summarized in
Figure 10A; (6–8)]. Daxx association to either PML-NBs
or chromatin depends on the status of the host cell and on
the interaction of Daxx with other nuclear proteins (e.g.
PML, ATRX), which can be regulated by post-transla-
tional modifications. Recently, Ishov et al. (9) observed
that cell cycle dependent phosphorylation regulates the
exit of Daxx from PML-NBs prior to assembly to
ATRX and chromatin associated proteins like histone
deacetylases, acetylated histone H4 and Dek at condensed
chromatin regions (10).
So far, the mechanisms of negative transcriptional
regulation by Daxx remain only poorly understood,
although Daxx association with repressive chromatin
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remodelling complexes has been proposed [summarized in
Figure 10B; (10,11)]. Recently, it was shown that Daxx
interacts with ATRX, a large protein of 280 kDa contain-
ing a putative ATPase/helicase domain, homologous to
members of the ‘Switch/Sucrose non-fermentable’ (SWI/
SNF) family of chromatin remodelling proteins (9,12,13).
In addition, ATRX contains a ‘plant homeodomain’,
similar to the DNA methyltransferase 3 family of
proteins (14,15). Daxx interacts with ATRX through its
NH2-terminal PAH1 domain (‘paired amphipathic alpha
helix’) (9,12,13). Furthermore, Daxx recruits ATRX to the
PML-NBs and interferes with ATRX-mediated transcrip-
tional repression [summarized in Figure 10A; (9)]. These
results suggest that Daxx regulates ATRX activity by
altering its localization in the nucleus. The association
between ATRX and PML-NBs also supports the observa-
tion that these nuclear bodies regulate diverse cellular
processes by modulating transcription.
Others reported that Daxx is an H3.3-specific histone
chaperone and cooperates with ATRX in replication-
independent chromatin assembly at telomeres (16).
Moreover, ATRX and H3.3 play essential roles in main-
taining telomere chromatin (17,18). Further insight into
H3.3-specific deposition pathways was gained by identify-
ing the highly conserved N terminus of Daxx as the direct
binding partner of H3.3. It was shown that recombinant
Daxx assembles H3.3/H4 tetramers on DNA templates,
and that deposition and remodelling of H3.3-containing
nucleosomes is catalysed by the Daxx/ATRX complex
(19). Although originally associated with euchromatic
sites of active transcription, H3.3 has recently been
found associated with regulatory elements and constitu-
tive heterochromatin (20–22). In summary, Daxx alone or
in a complex with ATRX was observed to most presum-
ably repress transcription by effectively assembling
H3.3-containing nucleosomes (16).
Ad are non-enveloped viruses with an icosahedral
capsid and linear double-stranded DNA (23). The viral
genome includes transcription units encoding 40 regula-
tory and structural proteins, and usually two non-coding
RNAs (‘virus-associated RNAs’), depending on the
serotype. Ad5 proteins are derived from early (E1A,
E1B, E2A, E2B, E3 and E4) or late (L1–L5) transcription
units. The E1A region is the first transcription unit
activated following Ad5 infection (24,25). Mechani-
stically, E1A proteins stimulate the infected cell to enter
S phase and are required to promote the transcription of
other early viral genes (26–28). The function of the early
region E1B-55K protein is more diverse. As a multifunc-
tional phosphoprotein, it promotes efficient viral replica-
tion via a number of different mechanisms. In the early
phase of productive Ad5 infection, E1B gene products
counteract anti-proliferative processes induced by the
host cell (29–31). Additionally, E1B-55K controls efficient
late viral protein production by stimulating preferential
cytoplasmic accumulation and translation of viral late
mRNAs during the late phase of infection (32,33).
Multiple functions of E1B-55K require interaction with
viral ‘early region 4 open reading frame protein 6’
(E4orf6). Together, both proteins assemble a Skp,
Cullin, F-box (SCF)-like E3-ubiquitin ligase complex,
initiating proteasomal degradation of cellular targets
such as p53, Mre11, DNA ligase IV, integrin a3 subunit
and Bloom-helicase (34–38). In contrast, we recently dis-
covered that E1B-55K antagonizes the innate antiviral
activities of Daxx by targeting the cellular protein for
E4orf6-independent proteasomal degradation (1).
Here, we demonstrate that in addition to Daxx, the
nuclear, chromatin remodelling factor ATRX represses
Ad5 replication in infected human cells. We observed sig-
nificantly enhanced viral gene expression after limiting
functional Daxx/ATRX chromatin remodelling complexes
in the nucleus. These data provide evidence that chromatin
modulating proteins play amajor role in a host cell intrinsic
defensemechanism against adenoviruses.We observed that
ATRX protein concentrations are antagonized by
proteasomal degradation via the E1B-55K/E4orf6 E3 ubi-
quitin ligase complex during Ad5 productive infection. Our
findings affect future studies on Ad chromatinization and
influence further research areas. As Ad-based vectors are
frequently used in gene therapy, understanding viral gene
expression within the host improves vector efficacy.
Considering the fundamental importance of chromatin for-
mation in host-cell gene regulation, investigating whether
Ad transcription is regulated by cellular chromatin
remodelling will contribute to the identification of new
therapeutic targets to limit or prevent virus-mediated
diseases and mortality of infected patients.
MATERIALS AND METHODS
Cell culture
Hep reDaxx and Hep Daxx PAH were established using
parental lentivirus vector pLKO-shDaxx2 (39) and insert-
ing yellow fluorescent protein (EYFP)-Daxx and EYFP-
hDaxx_PAH1 (39). For the Daxx/ATRX knockdown,
we constructed a lentivirus for double depletion of Daxx
and ATRX (pLKO-shDaxx/ATRX) by replacing the
shPML-siRNA sequence with a short hairpin RNA
against ATRX (50-CGACAGAAACTAACCCTGTAA-30)
(40) in a lentivirus designed for simultanous depletion of
Daxx and PML (41). A scrambled shRNA-expressing lenti-
virus was used as negative control. Lentivirus supernatants
were prepared by co-transfection of HEK293T cells with
the respective pLKO vector, pVSV-G (expressing the
vesicular stomatitis virus (VSV) envelope protein) and
pCMV.DR8.91 (expressing lentivirus helper functions), as
described previously (42). Stable cell lines were selected
using puromycin (initially 1mg/ml and then reduced to
0.5mg/ml during subsequent passage). H1299 Cullin-5
negative cells and the H1299 control cell line were described
previously (37,43). Daxx-depleted U2OS cells
(U2OS+shDaxx) were generated by transduction of lenti-
virus vectors expressing shRNA targeted to the coding
strand sequence 50-GGAGTTGGATCTCTCAGAA-30
located at nt 626–643 in Daxx (44). HepaRG cell lines
(1,39,45), HEK293 cells (46), p53 negative human cell line
H1299 (47) and osteosarcoma cell line U2OS (48) were
grown in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum, 100U of penicillin and
100mg of streptomycin per millilitre in a 5% CO2
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atmosphere at 37C. For HepaRG cells, the media was
supplemented with 5mg/ml of bovine insulin and 0.5mM
of hydrocortisone.
Plasmids, mutagenesis and transient transfections
Ad5 proteins examined in this study were expressed from
their respective complementary DNA under the control of
the cytomegalo virus (CMV) immediate early promoter,
derived from pcDNA3 vector (Invitrogen), to express
E1B-55K and E4orf6 (49,50). Luciferase reporter con-
structs were generated by cloning polymerase chain
reaction (PCR)-amplified Ad promoter constructs
upstream of the promoterless firefly luciferase gene in the
pGl3-basic vector (Promega). The respective Ad promoters
were amplified from CAT vectors (kindly provided by
Shenk) with specific oligonucleotides, introducing a XhoI/
HindIII restriction site (see Table1). For transient transfec-
tions, cells were treated as described previously (1). Plasmid
pEGFP-ATRX (51) was a kind gift from Picketts.
Viruses
H5pg4100 served as the wild-type Ad5 parental virus in
this study (52). The mutant viruses H5pm4149 and
H5pm4154 were generated as described recently (53).
Both viruses carry stop codons in the E1B-55K
(H5pm4149) or E4orf6 (H5pm4154) open reading frames
and do not express the respective viral protein (54). The
H5pm4139 was generated carrying amino acid changes in
the (elongins B and C) BC1 and BC2 box motifs of E4orf6
resulting in a drastically reduced ability to associate with
the Ad5 E3 ubiquitin ligase complex compared with the
E4orf6 protein from wild-type virus (53). Viruses were
propagated and titrated in HEK293 monolayer cultures.
Infections were performed as described previously (55). To
measure virus growth, infected cells were harvested 24, 48
and 72 h post-infection and lysed by three cycles of freeze
thaw. The cell lysates were serially diluted in Dulbecco’s
modified Eagle’s medium for infection of HEK293 cells,
and virus yield was determined by quantitative E2A-72K
immunofluorescence staining 24 h after infection (52).
Viral DNA replication was monitored by quantitative
PCR using E1B-specific primers (E1B-fwd 30-CGCGGG
ATCCATGGAGCGAAGAAACCCATCTGAGC-50;
E1B-rev 30-CGGTGTCTGGTCATTAA GC TAAAA-50)
exactly as described previously (50). PCR products were
analysed on a 1% agarose gel and quantified using the
G-Box system and Gene-Tools software (Syngene).
Amount of viral particles was monitored by quantitative
PCR. HepaRG cells were infected with wild-type virus
H5pg4100, harvested at 48 h post-infection (h. p. i.),
total cell extracts were prepared and treated with protein-
ase K. Quantitative real-time PCR was performed using
hexon-specific primers (hexon-qPCR-fw: 50-CGCT GGA
CATGACTTTTGAG-30; hexon-qPCR-rev: 50-GAACGG
TGTGCGCAGGTA-30). Ad5 H5pg4100 bacmid DNA
was used as a control to obtain a standard curve.
Quantitative real-time PCR analysis
Subconfluent cells were infected with wild-type virus and
harvested at 48 h. p. i. Total RNA was isolated with
‘Trizol reagent’ (Invitrogen) as described by the manufac-
turer. The amount of total RNA was measured, and one
microgram of RNA was reverse transcribed using the
‘Transcriptor High Fidelity cDNA Synthesis Sample Kit’
from Roche including anchored-oligo(dT)18 primer
specific to the poly(A)+RNA. Quantitative real-time
(qRT) PCR was performed with a first strand method in
a Rotor-Gene 6000 (Corbett Life Sciences, Sydney,
Australia) in 0.5ml of reaction tubes containing a 1/100
dilution of the cDNA template, 10 pmol/ml of each syn-
thetic oligonucleotide primer, 12.5ml/sample ‘Power
SYBR Green PCR Master Mix’ (Applied Biosystems).
The PCR conditions were as follows: 10 min at 95C, 55
cycles of 30 s at 95C, 30 s at 55C–62C (depending on
the primer set) and 30 s at 72C. The average Ct value was
determined from triplicate reactions, and levels of viral
mRNA relative to cellular 18S rRNA were calculated as
described recently (56). The identities of the products
obtained were confirmed by melting curve analysis.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation assay (ChIP) analysis was
performed as described previously with somemodifications
(57,58). Proteins were cross-linked to DNA with 1% for-
maldehyde in phosphate buffered saline for 10min at RT.
The reaction was quenched, cells were washed with phos-
phate buffered saline and harvested by scraping off the
dish. Nuclei were isolated by incubating cross-linked cells
with 500 ml of buffer I [50 mMHepes-KOH, 140mMNaCl,
1mM ethylenediaminetetraacetic acid (EDTA), 10%
glycerol, 0.5% NP-40, 0.25% Triton X-100] for 10min
on ice and pelleted by centrifugation. Nuclei were subse-
quently washed with 500 ml of buffer II (10mM Tris–HCl,
200mM NaCl, 1mM EDTA, 0.5mM (EGTA) ethylene
glycol tetraacetic acid), pelleted again and resuspended in
500 ml of buffer III [1% sodium dodecyl sulphate (SDS),
10mM EDTA, 50mM Tris–HCl]. Chromatin was frag-
mented by sonication using a BioruptorTM (Diagenode)
to an average length of 100–300 bp. After addition of 10%
Triton X-100, cell debris was pelleted by centrifugation and
supernatants were collected. Chromatin was diluted with
buffer (0.01% SDS, 1.1% Triton X-100, 1.2mM EDTA,
16.7mMTris–HCl, 167mMNaCl). To reduce non-specific
background, chromatin was pre-incubated with
salmon-sperm DNA protein-A agarose beads (Upstate).
Antibodies (Ab) were added and incubated for 16 h at
4C. The 50 ml of agarose beads were added to precipitate
Table 1. Oligonucleotide sequences used to amplify specific Ad
promoters
Primer name Primer sequence
E1A fwd 50 ATACTCGAGCATCATCAATAATATACCTTA
TTTTGGATTGA 30
E1A rev 50 TATAAGCTTGTCGGAGCGGCTCGGAG 30
E1B fwd 50 ATACTCGAGGTGTCTAGAGAATGCAATAGTAG 30
E1B rev 50 ATAAAGCTTTAACCAAGATTAGCCCACGG 30
E2 early fwd 50 ATACTCGAGTAGGATTGCCTGACGAGGCG 30
E2 early rev 50 ATAAAGCTTTACTGCGCGCTGACTCTTAAGG 30
MLP fwd 50 ATACTCGAGCTCACAGATTTGCATTTCCCA 30
MLP rev 50 ATAAAGCTTACAGCGATGCGGAAGAGA 30
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the chromatin immunocomplexes for 4 h at 4C. Beads
were washed once with low-salt buffer (0.1% SDS, 1%
Triton X-100, 2mM EDTA, 20mM Tris–HCl, 150mM
NaCl), once with high-salt buffer (0.1% SDS, 1% Triton
X-100, 2mM EDTA, 20mM Tris–HCl, 500mM NaCl),
once with LiCl-wash buffer (0.25M LiCl, 1% Nonidet
P-40, 1% Na-deoxycholate, 1mM EDTA, 10mM Tris–
HCl) and twice with TE buffer. Chromatin was eluted
from the beads in elution-buffer (50mM Tris–HCl (pH
8.0), 10mM EDTA, 1% SDS) for 10min at 95C.
ProteinaseK was added for protein degradation, and
samples were incubated for 1 h at 55C. To prepare input
controls, samples were treated like IP samples except that
non-specific Abs were used. qRT PCR analysis was per-
formed using a Rotor Gene 6000 (Corbett Life Sciences)
in 0.5ml of reaction tubes containing 1/100 dilution of the
precipitated chromatin, 10 pmol/ml of each synthetic oligo-
nucleotide primer (see Table 2), 5 ml/sample SYBR Green
PCR Master Mix (Applied Biosystems). The PCR condi-
tions used: 7min at 95C, 45 cycles of 12 s at 95C, 40 s at
60C and 15 s at 72C. The average Ct-value was
determined from triplicate reactions and normalized
against non-specific immunoglobulin G (IgG) controls
(sc-2027; Santa Cruz Biotechnology) with standard
curves for each primer pair. The identities of the products
obtained were confirmed by melting curve analysis.
Luciferase reporter assays
For dual luciferase assays, subconfluent cells were trans-
fected as described previously (55,59), using 0.5 mg of
reporter and 0.5 mg of pRL-TK (Promega), which
expresses Renilla luciferase under the control of the
herpes simplex virus thymidine kinase promoter. As
described by the manufacturer (Promega) for dual
luciferase assays, total cell extracts were prepared 48 h
after transfection, and retinal ganglion cells (RGC)
firefly luciferase activity was assayed with 5 ml of lysed
extract in an automated luminometer (Berthold
Technologies). All samples were normalized for transfec-
tion efficiency by measuring Renilla luciferase activity. All
experiments shown were performed as triplicates, and data
are presented as mean values.
Micrococcal nuclease nuclease accesibility assay
Cell pellets were lysed in a hypotonic buffer (10mM Tris–
HCl (pH 7.4), 10mM KCl, 15mM MgCl2) on ice for
10 min. Nuclei were pelleted by centrifugation and
resuspended in Micrococcal nuclease (MNase) digestion
buffer [0.32M sucrose, 50mM Tris–HCl (pH 7.5), 4mM
MgCl2, 1mM CaCl25, 0.1mM phenylmethylsulfonyl
fluoride (PMSF)] supplemented with 20 U MNase and
incubated at 37C for varying periods. The MNase
reaction was stopped by the addition of 10mM EDTA
followed by centrifugation. The pellet was then
resuspensed in MNase digestion buffer supplemented
with 10mM EDTA and RNase and incubated at 37C
for 30 min. The DNA was extracted and purified by
standard procedures. Digested chromatin was analysed
on a 1.4% agarose gel using the G-Box system and
Gene-Tools software (Syngene). Band intensities were
quantified with ImageJ and analysed with GraphPad
Prism software.
Protein analysis and Ab
Cells were resuspended in radioimmunoprecipitation
buffer (RIPA) buffer (50mM Tris–HCl (pH 8.0),
150mM NaCl, 5mM EDTA, 1mM dithiothreitol
(DTT), 0.1% SDS, 1% NP-40, 0.1% Triton X-100,
0.5% sodium deoxycholate) containing 1% (v/v) PMSF,
0.1% (v/v) aprotinin, 1 mg/ml of leupeptin, 1 mg/ml of
pepstatin, 1mM DTT, 25mM iodacetamide and 25mM
N-ethylmaleimide. After 1 h on ice, the lysates were
sonicated, and insoluble debris was pelleted at 15 000g/
4C. Fractionation of soluble and chromatin-rich frac-
tions was reported recently (60). For immunoprecipitation
and immunoblotting, protein lysates were treated as
described recently (61). Primary Ab specific for Ad
proteins used in this study included E1A mouse
monoclonal antibody (MAb) M73 (62), E1B-55K mouse
MAb 2A6 (63), E2A-72K mouse MAb B6-8 (64), E4orf6
MAb RSA3 (65) and Ad5 rabbit polyclonal serum L133
(66). Primary Ab specific for cellular proteins included
ATRX rabbit Ab H-300 (Santa Cruz Biotechnology),
ATRX mouse MAb clone 39F (kindly provided by
Gibbons), Daxx rabbit polyclonal Ab 07-471 (Upstate/
Millipore), anti-histone H3.3 rabbit polyclonal Ab
ab62642 (Abcam), PML rabbit poyclonal Ab H-238
(Novus Biologicals) and ß-actin mouse MAb AC-15
(Sigma-Aldrich). EYFP epitopes were detected with
anti-green fluorescent protein (GFP) rabbit Ab ab290
(Abcam). Secondary Ab conjugated to horseradish perox-
idase to detect proteins by immunoblotting were
anti-rabbit IgG and anti-mouse IgG (Jackson/Dianova).
RESULTS
Efficient Ad5 replication is restricted by Daxx and ATRX
Ad5 replication centres establish in the vicinity of nuclear
PML-NBs, as demonstrated by recruitment of viral and
host proteins required for DNA replication, transcription
and gene expression to these nuclear foci (67). We previ-
ously showed that the transcriptional repressor and
PML-NB resident factor Daxx suppresses Ad5 replication
early in infection (1). Daxx is linked to transcriptional
repression via interaction with ATRX in a functional,
ATP-dependent, SWI/SNF chromatin remodelling
complex, recruiting histone deacetylase (HDACs) to sites
Table 2. Oligonucleotide sequences used to amplify Ad DNA in
ChIP assays
Primer name Primer sequence
E1A fwd 50 TCCGCGTTCCGGGTCAAAGT 30
E1A rev 50 GTCGGAGCGGCTCGGAG 30
E1B fwd 50 GGTGAGATAATGTTTAACTTGC 30
E1B rev 50 TAACCAAGATTAGCCCACGG 30
E2 early fwd 50 TACTGCGCGCTGACTCTTAAGG 30
E2 early rev 50 ATGGCGCTGACAACAGGTGCT 30
MLP fwd 50 TGATTGGTTTGTAGGTGTAGG 30
MLP rev 50 ACAGCGATGCGGAAGAGA 30
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of active transcription and depositing histone variant
H3.3. To analyse the role of Daxx-associated ATRX
during Ad5 infection, we performed experiments in a
non-transformed human hepatocyte cell line, HepaRG,
expressing shRNAs targeting either Daxx, ATRX or
both (1,39). Before our analysis, we investigated cell pro-
liferation in Daxx- and ATRX knockdown cells and
observed no significant difference. Moreover, immuno-
fluorescence analysis showed that neither Daxx nor
ATRX depletion affected formation of PML-NB struc-
tures in the nucleus (data not shown). Previously, we
found that depletion of transcription factor Daxx
correlated with enhanced Ad5 early gene expression.
Consistent with this, Daxx knockdown increased produc-
tion of Ad5 particles 4-fold, 72 h post infection [h. p. i.;
Figure 1A; (1)]. As expected, the repressive effect of Daxx
was partially rescued by expressing of a EYFP-Daxx
fusion protein in the Daxx-depleted cells (1,39).
Reconstituted Daxx substantially reduced Ad5 virus
growth in these Hep reDaxx cells [Figure 1A; (1)]. To in-
vestigate the effect of ATRX on Ad5 progeny production,
we determined virus growth in ATRX-depleted cells (Hep
shATRX; Figure 1A). As with Hep shDaxx cells, ATRX
depletion enhanced progeny virus production 2 - (48 h. p.
i.) to 4-fold (72 h. p. i.) compared with control cells (Hep
parental/Hep neg; Figure 1A). To reveal whether Daxx
and ATRX clearly act together on the repression of viral
progeny production rather than in a parallel manner, we
generated a double knockdown cell line depleting Daxx
and ATRX simultaneously (Hep shDaxx/shATRX). We
observed an increased production of Ad5 progeny 2-
(48 h. p. i.) to 4-fold (72 h. p. i.) in comparison with the
cell lines expressing a functional Daxx/ATRX chromatin
remodelling complex (Hep parental, Hep neg; Figure 1A).
These results suggest that both Daxx and ATRX mediate
repressive effects regarding Ad5 progeny production. To
further determine whether Daxx/ATRX nuclear localiza-
tion might affect Daxx/ATRX-dependent transcriptional
repression of viral gene expression, we also analysed Ad
gene expression in HepaRG cells depleted for endogenous
Daxx and expressing an EYFP-Daxx fusion protein with a
functional mutation in the sumo interacting motif (SIM),
completely abrogating Daxx association with PML-NBs.
Our analysis showed that Daxx SIM mutant cells support
efficient repression of Ad5 gene expression compared with
control cells (data not shown). Our findings strongly
suggest that repressive functions are achieved, despite in-
hibition of Daxx colocalization with PML-NBs in the SIM
mutation. As recent reports show that Daxx is degraded
during late adenovirus infection via an E1B-55K-
dependent, proteasomal pathway (1), we next analysed
the expression levels of Daxx and ATRX during Ad5 in-
fection (Figure 1B). Our data show stable expression of
shRNAs depleting either Daxx, ATRX or both (Hep
shDaxx; Hep shDaxx/shATRX) and/or ATRX (Hep
shATRX; Hep shDaxx/shATRX). Moreover, we con-
firmed Daxx reduction in Ad5 wild-type infected cells,
highly dependent on E1B-55K concentrations (Hep
parental; Hep shATRX; Hep reDaxx; Hep neg; Supple-
mentary Figure S1A). Hence, by monitoring ATRX levels
in infected cells, we observed reproducibly declined
concentrations (Hep parental; Hep shDaxx; Hep
reDaxx; Hep neg; Supplementary Figure S1A).
Therefore, we are tempted to speculate that efficient Ad
gene expression requires Daxx/ATRX elimination during
infection or at least limitation of the protein concentra-
tions to counteract the repressive activity determined by
both transcription factors. We further determined quanti-
tative PCR analysis to precisely quantify virus concentra-
tion using hexon-specific primers (Supplementary Figure
S1B). We observed reduced amount of Ad5 viral DNA
copies in cells depleted for Daxx and/or ATRX (Hep
shDaxx, Hep shATRX, Hep shDaxx/shATRX;
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Figure 1. Functional inhibition of Daxx/ATRX repressive complex ef-
ficiently stimulates Ad5 viral gene expression. Hepa RG cells were
infected with wild-type H5pg4100 at moi of 50 FFU per cell. (A)
Viral particles were harvested 24, 48 and 72 h. p. i., and virus yield
was determined by quantitative E2A-72K immunofluorescence staining
on HEK293 cells. Shown are averages from three independent experi-
ments. Error bars indicate the standard error of the mean. (B) Total
cell extracts were prepared and treated with proteinase K. PCR was
performed, and identicle amounts of PCR product were separated on
analytic agarose gels (1%) and quantified with Gene Snap Software
(Syngene). The results shown represent the averages from two inde-
pendent experiments.
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Supplementary Figure S1B).The results from these assays
are consistent with the data obtained by virus yield and
stengthen the hypothesis that Daxx and ATRX act
together, rather than in a parallel manner to repress
viral titer and gene expression. Similar effects were
observed monitoring viral DNA synthesis in infected
cells (Figure 1B). As with Ad5 progeny production,
DNA synthesis was more efficient in Daxx- and/or
ATRX-depleted cells (Figure 1B). These results suggest
that both cellular transcription factors mediate repressive
effects during Ad5 infectious cycle. To further test this
hypothesis, expression of viral early E1A
(Supplementary Figure S2A), E1B-55K (Supplementary
Figure S2B), E2A/DBP (Supplementary Figure S2C)
and late proteins hexon and fiber (Supplementary Figure
S2D) was monitored at different time points after Ad5
wild-type infection. Expression of E1A, E1B and E2A/
DBP was substantially increased in cells with reduced
amount of Daxx and/or ATRX (Hep shDaxx, Hep
shATRX, Hep shDaxx/shATRX; Supplementary Figure
S1B) and in comparison with the control cells (Hep par,
Hep neg, Hep reDaxx; Supplementary Figure S1B).
Consistent with this observation, we show an increase in
protein concentration of late hexon and fiber proteins in
infected Daxx- and/or ATRX-depleted cells (Supplemen-
tary Figure S2D).
Daxx/ATRX functional complex formation is essential to
repress Ad5 gene expression
So far, it was unclear whether Daxx and ATRX affect Ad
gene expression individually or impair Ad transcription by
assembling a functional SWI/SNF chromatin remodelling
complex. To test whether functional Daxx/ATRX
complexes affect Ad5 replication, we monitored virus
growth in a stable cell line depleted for endogenous
Daxx, expressing an EYFP-Daxx fusion protein lacking
73 amino acids spanning its ATRX-interacting PAH1
domain (Hep Daxx PAH). These cells express the same
amounts of Daxx and ATRX proteins but lack functional
cooperation and consequently Daxx/ATRX-mediated
transcriptional repression [Supplementary Figure 1A; see
(39)]. We found that Ad5 progeny production is enhanced
2- (48 h. p. i.) to 5-fold (72 h. p. i.) in infected cells lacking
functional Daxx/ATRX complex formation (Hep Daxx
PAH), compared with parental cells (Hep par), cells
transduced with scrambled shRNA (Hep neg) or cells ex-
pressing an EYFP Daxx fusion protein re-introduced into
the Daxx-depleted cell line (Hep reDaxx; Figure 1A). This
effect is not due to altered cell proliferation in the Hep
Daxx PAH line compared with control cells or any altered
localization of PML, Daxx or ATRX in uninfected or
Ad5-infected cells (data not shown). Similar results were
obtained from studies monitoring viral DNA synthesis
(Figure 1B; Supplementary Figure S1B) and expression
of viral proteins (Supplementary Figure S2). Taken
together, our findings indicate that although both
cellular proteins are present, Ad5 repression depends on
a functional Daxx/ATRX interaction and most likely
occurs at the transcriptional level.
Functional Daxx/ATRX complex is sufficient to repress
Ad5 promotor activity and mRNA synthesis
Next, we investigated whether Ad5 early promoters are
targeted by Daxx and/or ATRX-mediated repression
and whether this can be reversed by functionally inhibiting
the repressive SWI/SNF complex. First, we analysed
whether early and late Ad5 mRNA levels are affected by
Daxx and/or ATRX in Ad5 wild-type virus-infected cells.
Viral early E1A, E1B, E2A/DBP and hexon mRNA pro-
duction was lower in parental cells and in cells expressing
reintroduced EYFP-Daxx [Hep reDaxx; (1)], compared
with cells lacking a functional Daxx/ATRX complex for-
mation (Hep Daxx PAH, Figure 2). Similar results were
obtained for hexon mRNA expression, suggesting either
an impact of enhanced synthesis of early gene products or
direct repression of the late promoter (Figure 2). Next, we
constructed luciferase expression vectors, controlled by
adenoviral early promoters (E1A, E1B, E2 early and
MLP) and measured luciferase expression in different
HepaRG cell lines (Figure 3A).
Compared with parental control cells and cells express-
ing an EYFP-Daxx fusion protein [Hep reDaxx; (1)], the
absence of either Daxx and/or ATRX stimulated 5-fold
expression from E1A and E1B promoters, 8-fold from
the E2 early promoter and 4-fold from the MLP
promoter (Figure 3A).
As Daxx contains no DNA binding region, it is
supposed that ATRX is the molecular bridge connecting
the complex to chromatin. To show direct association of
ATRX with adenovirus promoters, we performed ChIP in
virus-infected HepaRG cells, using ATRX Ab, unrelated
IgG control Ab and Ad promoter-specific primers
(Table 2; Figure 3B). The results show that ATRX is
associated with Ad promoters in infected Hep parental
cells 24 h after infection (Figure 3B). To support the
model that ATRX recruits Daxx to Ad promoters, we
inclued Hep shATRX cells to our ChIP analysis. As
anticipated, we did not observe ATRX chromatin
binding to Ad promoter sequences in the shATRX cells,
excluding unspecific background of the ATRX-specific
Ab. To further elucidate whether ATRX bound to adeno-
viral promoters is Daxx independent, we carried out add-
itional ChIP experiments in Daxx-depleted (Hep shDaxx)
cells and in cells without a functional Daxx/ATRX
complex (Hep Daxx PAH). We observe that ATRX is
targeted to Ad5 promoters independent of Daxx, as we
were still able to detect ATRX recruitment (Figure 3B).
Conclusively, we clarified the interdependence of Daxx
and ATRX when targeting viral promoters illustrating
an ATRX-dependet process, independent of the complex
formation with Daxx. Taken together, these results
indicate that ATRX relocalizes Daxx to Ad promoter
regions, and that both transcription factors mediate
repression of Ad5 productive replication.
ATRX expression in ATRX knockout cells is sufficient to
repress Ad5 gene expression
Next, we analysed Ad5 replication in U2OS cells, which
lack ATRX protein expression (Figure 4A; 39,64,68).
First, we monitored Daxx protein levels and observed
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significant reduction in the presence of wild-type virus
(Figure 4A). Consistent with our observations in infected
HepaRG cells (Supplementary Figure S1A), Daxx was still
degraded in the absence of ATRX. This result confirms that
fact that inhibition of both repressors might occur via in-
dependent mechanisms. Next, we tested whether Daxx de-
pletion (Figure 4A) affects adenovirus production and gene
expression in U2OS cells. We observed no effect on adeno-
virus progeny production in the absence of Daxx
(U2OS+shDaxx; Figure 4B). When ATRX was provided
in trans, expressed from a pEGFP construct with 41% ef-
ficiency of transfection (data not shown), virus growth was
3-fold less than in control cells, where Ad5 was not re-
pressed (Figure 4B). The same result was obtained when
we quantified the amount of viral DNA copies (Figure 4C)
and viral DNA synthesis. (Figure 4D). Taken together,
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Figure 2. Daxx/ATRX complex represses Ad5 mRNA synthesis.
HepaRG cells were infected with H5pg4100 Ad5 wild-type at moi of
50 FFU/cell. Then, 24 h. p. i., total RNA was extracted, reverse tran-
scribed and quantified by RT-PCR using primers specific for E1A (E1A
fwd: 50-GTGCCCCATTAAACCAGTTG-30; E1A rev: 50-GGCGTTT
ACAGCTCAAGTCC-30), E1B-55K (E1B fwd: 50-GAGGGTAACT
CCAGGG TGCG-30; E1B rev: 50-TTTCACTAGCATGAaGCAAC
CACA-30, E2A/DBP and hexon (hexon rev: 50-GAACGGTGTGCGC
AGGTA-30; hexon fwd 50-CGCTGGACATGACTTTTG AG-30. Data
were normalized to 18S rRNA levels (18S rRNA fwd: 50-cggctaccacatc-
caaggaa-30; 18S rRNA rev: 50-GCTGGAATTACCGCGGCT-30).
Values correspond to the mean of triplicates, and error bars indicate
the standard error of the mean.
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Figure 3. Daxx/ATRX complex mediates Ad transcriptional repres-
sion. (A) Hepa RG cells were transfected with luciferase reporter
plasmids under Ad promoter control (E1A, E1B, E2early, MLP).
Then, 48 h after transfection, samples were lysed, absolute luciferase
activity was measured. All samples were normalized for transfection
efficiency by measuring Renilla luciferase activity. Promoter activity
of E1A, E1B, E2early and MLP promoter in Hep parental cells was
normalized to 1. Mean and STD are from three independent experi-
ments. (B) HepaRG cells were infected with H5pg4100 Ad5 wild-ype at
moi of 50 FFU/cell. Then, 24 h. p. i. cells were fixed with formaldehyde
and analysed by ChIP assays (see ‘Material and Methods’ section). The
average Ct-value was determined from triplicate reactions and
normalized against non-specific IgG controls with standard curves for
each primer pair (Table 2). The y-axis indicates the percentage of
immunoprecipitated signal from the input (100%). The white dotted
line highlights values >1% of input, commonly stated as significant
chromatin/protein binding.
3538 Nucleic Acids Research, 2013, Vol. 41, No. 6
 at Periodicals D
ept on M
ay 1, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
A B
U2
OS
co
ntr
ol 
H5
pg4
10
0
H5
pm
41
49
m
oc
k
H5
pg4
10
0
H5
pm
41
49
m
oc
k
H5
pg4
10
0
H5
pm
41
49
m
oc
k
H5
pg4
10
0
H5
pm
41
49
m
oc
k
U2
OS
+
pE
GF
P-e
mp
ty 
U2
OS
+
pE
GF
P-A
TR
X 
U2
OS
+
shD
axx
  1     2      3            4      5      6          7      8      9          10    12     13          
0
4000
8000
12000
16000
20000
vi
ru
s 
yie
ld
 F
FU
/c
el
l
12000
24 h p.i.
48 h p.i.
72 h p.i.
U2
OS
co
ntr
ol U2
OS
+
pE
GF
P-e
mp
ty U2
OS
+
pE
GF
P-A
TR
X U2
OS
+
shD
axx
C D
0
200
400
600
800
1000
U2
OS
co
ntr
ol U2
OS
+
pE
GF
P-e
mp
ty U2
OS
+
pE
GF
P-A
TR
X U2
OS
+
shD
axx
0
2
4
6
8
10
24 h p.i.
72 h p.i.
vi
ra
l D
N
A 
sy
nt
he
sis
 (a
rbi
tra
ry
 u
ni
ts
) 
U2
OS
co
ntr
ol U2
OS
+
pE
GF
P-e
mp
ty U2
OS
+
pE
GF
P-A
TR
X U2
OS
+
shD
axx
n
u
m
be
r o
f v
ira
l D
N
A 
co
pi
es
 (x
10
00
)
1200
1400
Figure 4. Daxx/ATRX functional complex modulates productive Ad replication. U2OS cells were transfected with either empty vector or
pEGFP-ATRX plasmid expressing human ATRX 24h before infection with wild-type H5pg4100 virus or E1B-55K minus virus mutant
H5pm4149 at moi of 50 FFU per cell. (A) U2OS cells were harvested at 48 h. p. i., total cell extracts were prepared and proteins were separated
by SDS–polyacrylamide gel electrophoresis (PAGE) and subjected to immunoblotting using mouse ATRX-specific mouse Mab or Daxx-specific
rabbit Ab. Corresponding b-actin was included as a loading control. (B) Viral particles were harvested 24, 48 and 72 h. p. i., and virus yield was
determined by quantitative E2A-72K immunofluorescence staining on HEK293 cells. Averages from three independent experiments are shown. Error
bars indicate the standard error of the mean. (C) U2OS cells were harvested at 48 h. p. i., total cell extracts were prepared and treated with proteinase
K. Quantitative real-time PCR was performed using hexon-specific primers. Ad5 H5pg4100 bacmid was used to obtain a standard curve. The results
represent the averages from three independent experiments. Error bars indicate the standard error of the mean. (D) Total cell extracts were prepared
and treated with proteinase K. PCR was performed and identicle amounts of PCR product were separated on an analytic agarose gels (1%) and
quantified with Gene Snap Software (Syngene).
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depletion of Daxx in U2OS cells, lacking ATRX gene ex-
pression, did not show supportive effects on adenovirus
gene repression. Moreover, as with HepaRG cells (Figure
1B; Supplementary Figure S1B), amount of Ad5 DNA
copies (Figure 4C) and viral DNA synthesis (Figure 4D)
was reduced in U2OS cells when transfected with the
ATRX-encoding construct before infection. We note that
induction of Ad5 gene expression is more pronounced in
ATRX knockout (U2OS) than ATRX knockdown (Hep
shATRX) cells, likely owing to diverging ATRX concen-
trations. Next, we tested expression of viral early E1A,
E1B-55K, E4orf6 and late proteins (Supplementary
Figure S3) at different time points after Ad5 wild-type in-
fection in the different U2OS cells. Expression of all viral
proteins monitored was substantially reduced in cells ex-
pressing ATRX in trans (Supplementary Figure S3, lanes
7–9). Consistent with this observation, we showed no effi-
cient mRNA synthesis in infected U2OS cells stably ex-
pressing the ATRX transcription factor (Figure 5; U2OS
+EGFP-ATRX) in comparison with various control cells
(U2OS control, U2OS+EGFP-empty, U2OS+shDaxx).
These results indicate that both PML-NB components,
Daxx and ATRX, are negative regulators of Ad5 product-
ive replication.
ATRX protein levels are reduced during lytic Ad infection
in human cells
So far, various reports clearly demonstrate that Ad
disrupts PML-NBs in the early phase of infection via
relocalization into track-like structures. Our findings
show that the Daxx/ATRX complex can repress transcrip-
tion independent of PML-NB association. Therefore,
Ad-mediated track-like formation is most likely not
interfering with Daxx/ATRX repressive attributes. Con-
sequently, we proposed that efficient Ad gene expression
requires Daxx/ATRX inhibition during infection or at
least limitation of repressive activity by post-translational
modifications. We therefore monitored ATRX protein
levels in Ad-infected cells and observed that ATRX
concentrations are reduced during wild-type (wt)
(H5pg4100) lytic infection (Figure 6A). In contrast, we
observed no ATRX reduction in infected cells lacking
either E1B-55K (H5pm4149) or E4orf6 (H5pm4154;
Figure 6A). E1B-55K is likely the substrate recognition
unit, whereas E4orf6 assembles the cellular components
into Ad5 dependent E3 ubiquitin ligase. To determine
whether ATRX is a novel binding partner of E1B-55K,
we performed binding assays in Ad5 wild-type
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Figure 5. Daxx/ATRX functional complex modulates productive Ad5 mRNA synthesis. U2OS cells were transfected with either empty vector or
pEGFP-ATRX plasmid-expressing human ATRX 24h before infection with wild-type H5pg4100 virus or E1B-55K minus virus mutant H5pm4149 at
moi of 50 FFU per cell. Then, 24 h. p. i., total RNA was extracted, reverse transcribed and quantified by RT-PCR using primers specific for E1A,
E1B-55K, E4orf6 (E4orf6 rev: 50-CCCTCATAAACACGCTGGAC-30; E4orf6 fwd: 50-GCTGGTTTAGGATGGTGGTG-30) and hexon. Data were
normalized to 18S rRNA levels. Values correspond to the mean of triplicates, and error bars indicate the standard error of the mean.
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(H5pg4100), E1B-55K (H5pm4149) and E4orf6
(H5pm4154) mutant virus-infected cells lacking the re-
spective viral protein. Co-immunoprecipitation of
E1B-55K with ATRX-specific MAb revealed an
interaction between both factors during lytic Ad5 infec-
tion (Figure 6A, lanes 2 and 4), whereas no signal was
detected in the corresponding controls (Figure 6A, lanes
1 and 3). We detected nearly identical amounts of
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Figure 6. Proteasomal degradation of ATRX in infected and transfected cells. H1299 cells were infected with wild-type (H5pg4100) and mutant
viruses (H5pm4149, H5pm4154) at moi of 50 FFU per cell. (A) Total cell extracts were prepared 48 h. p. i., and proteins were separated by SDS–
PAGE and subjected to immunoblotting using mouse MAb 2A6 (E1B-55K), mouse MAb RSA3 (E4orf6), Daxx specific rabbit Ab and
ATRX-specific mouse MAb clone 39F. b-actin was included as a loading control. Co-immunoprecipitation (IP) of E1B-55K was performed with
ATRX-specific mouse MAb clone 39F followed detection of co-precipitated E1B-55K with mouse MAb 2A6. (B) Infected cells (as aforementioned)
were treated for 6 h with proteasome inhibitor (+MG 132), before total cell extracts were prepared and specific proteins detected as described in A.
(C) H1299 cells were transfected with pcDNA3-derived plasmids expressing wild-type E1B-55K, E4orf6 or a combination of both. Cells were
harvested 48 h. p. i. Total cell extracts were prepared, and specific proteins were immunoprcipitated and detected as described in (A).
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co-precipitated E1B-55K protein, although the ATRX
input levels were greatly altered, dependent on
proteasomal degradation. This might be due to limiting
conditions of Ab-coupled protein A-sepharose in these
IP experiments, which ensures complete saturation of
the beads with ATRX Ab. To control co-
immunoprecipitation of E1B-55K with ATRX-specific
MAb, we repeated the experiment in the Hep shATRX
cells in the absence of ATRX and did not observe any
non-specific band (data not shown). The decrease in
ATRX seen in wild-type infected cells was abolished
when we treated the cells with proteasome inhibitor MG
132 (Figure 6B, lanes 2 and 6). These data demonstrate
that in contrast to E1B-55K-dependent degradation of
Daxx (1), ATRX is targeted via a proteasomal pathway,
which requires E1B-55K in cooperation with E4orf6. To
test our hypothesis, we first analysed the levels of ATRX
protein in plasmid-transfected cells in the absence of a
viral background (Figure 6C).
Expression of wild-type E1B-55K or E4orf6 alone had
no effect on endogenous ATRX protein concentrations
(Figure 9C, lanes 2 and 3), whereas expression of both
(Figure 6C, lane 4) diminished ATRX protein levels simi-
larly to wild-type-infected cells (Figure 6A, lane 2).
ATRX protein is degraded via an Ad5 E1B-55K/E4orf6-
dependent E3 ubiquitin ligase complex
Ad5 E1B-55K and E4orf6 assemble an E3 ubiquitin ligase
complex containing the Cullin family member Cullin5,
Elongins B and C, and the RING protein Rbx1 (69).
Recently, it was shown that degradation of p53 is signifi-
cantly impaired in a Cullin5 knockdown cell line (43). On
the basis of these data, we examined ATRX protein levels
in infected Cullin5 negative and control H1299 cells
[Figure 7A; (37)]. Reduction of Daxx and Mre11 is de-
pendent on Cullin5, as no decrease was observed in
Cullin5 negative H1299 cells infected with wild-type
(Figure 7A, lane 6). These data demonstrate that similar
to known targets of the Ad5 E3 ubiquitin ligase, ATRX is
degraded via a Cullin5-dependent proteasomal pathway,
which requires E1B-55K and E4orf6. In addition to
Cullin5, E4orf6 was previously shown to assemble with
cellular proteins Rbx1 and Elongins B/C to form the E3
ubiquitin ligase to degrade cellular factors in presence of
E1B-55K (69). Moreover, E4orf6 was shown to bind
Elongins B and C via two conserved BC box motifs.
Next, we examined ATRX protein levels in H1299 cells,
infected with a E4orf6 virus mutant carrying point muta-
tions in this BC Box, abrogating the formation of the Ad5
ubiquitin ligase complex. Our results strongly implicate
that activity of the E1B-55K/E4orf6 ligase complex is es-
sential to reduce ATRX protein concentration (Figure 7B,
lane 5). Consistent with previous publications we
observed, Daxx reduction, but no degradation, of Mre11
during lytic infection with the BC-box virus mutant
H5pm4139 (Figure 7B, lane 5). This confirms the fact
that formation and ligase activity of the E1B-55K/
E4orf6 complex is essential for ATRX degradation via
host cell proteasomes.
To further interconnect our conclusions, we monitored
ATRX protein levels in the soluble and chromatin-rich
fraction of Ad5-infected cells. Unexpectedly, Daxx and
ATRX were reproducibly declined during wt (H5pg4100)
lytic infection in the chromatin fraction, although only a
minor amount of the viral proteins could be detected in
this fraction (Figure 7C). In contrast, we observed no re-
duction of the cellular chromatin-associated factors in
infected cells lacking E1B-55K (H5pm4149; Figure 7C,
lanes 3 and 6).
Ad-mediated inactivation of Daxx/ATRX functions affects
H3.3 association with Ad promoters and chromatin
condensation
Daxx is involved in deposition of cellular histone variant
H3.3 on actively transcribed genes. Recent reports showed
that Daxx either alone or in complex with ATRX actively
assembles H3.3-containing nucleosomes (19,20,70). In line
with this, Ad DNA was recently observed to preferentially
associate with H3.3 (71), indicating that chromatinization
by a replication-independent mechanism may play a so far
unknown role during Ad life cycle. To enrich the novelty
of our findings and giving the fact that we observed Daxx/
ATRX complex mainly degraded in the chromatin
fraction of the host cell, we experimentally assessed the
effects of Ad5 wt infection on Daxx/ATRX-dependent
H3.3 recruitment on viral promoters (Figure 8). ChIP
analysis showed that H3.3 was found to be complexed
with viral promoters (E1A, E1B) 24 h after infection of
Hep parental cells (5 fluorescent forming units (FFU)/
cell). Although using infected cells, treated with higher
amounts of virus particles (100 FFU/cell), inducing
Daxx and ATRX reduction, H3.3 association at viral pro-
moters was significantly lost [promoter binding beyond
1%; (72)]. To determine whether this observation could
be linked to efficient Ad-dependent Daxx/ATRX
proteasomal degradation, we examined H3.3 loss from
Ad promoters in infected HepaRG knockdown and
control cells. We observed that the majority of H3.3 was
lost from the viral DNA, although cells were treated with
a very low multiplicity of infection (moi) of 5 FFU/cell
(Hep shDaxx cells; Hep shATRX cells; Figure 8A).
We observed the same result in infected Hep Daxx PAH
cells in the absence of a functional Daxx/ATRX complex
(Figure 8A). To validate functional restriction of the
Daxx/ATRX complex via Ad-dependent proteasomal
degradation, we monitored Daxx and ATRX protein
levels in infected HepaRG cells used for our ChIP
analysis. Daxx and ATRX protein concentrations repro-
ducibly declined during Ad wt (H5pg4100) infection with
a moi of 100 FFU/cell after 24 h (Figure 8B). As
anticipated, detection of Daxx and ATRX proteins also
failed within the HepaRG shDaxx cells or HepaRG
shATRX cells (5 FFU/cell), illustrating the negative
control in these experiments. In contrast, in Hep
parental cells, Daxx or ATRX reduction was not yet
observed 24 h. p. i. after infection with minor amount of
infectious particles (5 FFU/cell; Figure 8B). Consistent
with recent reports that Daxx assembles H3.3/H4 tetra-
mers on DNA templates, and that deposition and
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remodelling of H3.3-containing nucleosomes is catalysed
by the Daxx/ATRX complex, we could observe that in
cells depleted for Daxx and/or ATRX as well as in cells
without the functional complex (Hep Daxx PAH), H3.3
fraction bound to Ad promoter sequences of E1A and
E1B transcription units is reduced compared with
infected control cells (Hep par; 5 FFU/cell). Ad5 impact
on Daxx-dependent chromatinization via H3.3 deposition
is consistent with our findings that functional Daxx/
ATRX chromatin remodelling complex is inactivated
during the course of Ad5 infection. This is further consist-
ent with results from the infection studies, showing that
E1B-55K-dependent Daxx degradation (Hep par; 100
FFU/cell) and E1B-55K/E4orf6-dependent ATRX
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Figure 7. ATRX is reduced via the E1B-55K/E4orf6 E3 ubiquitin ligase complex. (A) H1299 control and shCullin5 cells were infected with wild-type
(H5pg4100) and mutant viruses (H5pm4149, H5pm4154) at moi of 50 FFU per cell. Total cell extracts were prepared 48 h. p. i., and proteins were
separated by SDS–PAGE and subjected to immunoblotting using mouse MAb 2A6 (E1B-55K), mouse MAb RSA3 (E4orf6), Daxx- and
Mre11-specific rabbit Ab and ATRX-specific mouse MAb clone 39F. b-actin was included as a loading control. (B) H1299 cells were infected
with wild-type (H5pg4100) and mutant viruses (H5pm4149, H5pm4154, H5pm4139) at moi of 50 FFU per cell. (A) Total cell extracts were prepared
48 h. p. i., and proteins were separated by SDS–PAGE and subjected to immunoblotting using mouse MAb 2A6 (E1B-55K), mouse MAb RSA3
(E4orf6), Daxx- and Mre11-specific rabbit Ab and ATRX-specific mouse MAb clone 39F. b-actin was included as a loading control. (C) H1299 cells
were infected with wild-type (H5pg4100) and E1B minus mutant virus (H5pm4149) at moi of 50 FFU per cell. Then, 48 h. p. i., total cell extracts
were prepared after fractionation of soluble and chromatin fractions as described recently (60). Proteins were separated by SDS–PAGE and subjected
to immunoblotting using Mre11-specific rabbit Ab, Daxx-specific rabbit Ab and ATRX-specific mouse MAb clone 39F, mouse MAb 2A6 (E1B-55K)
and mouse MAb RSA3 (E4orf6).
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Figure 8. Inhibition of functional Daxx/ATRX complex modulates chromatin structure and condensation. Hepa RG cells were infected with
H5pg4100 Ad5 wild-type at moi of 5 and 100 FFU/cell. 24 h p.i. (A) and 48 h p.i. (B), cells were fixed with formaldehyde and analysed by ChIP
assays (see ‘Material and Methods’ section). Isolated chromatin was precipitated with histone variant H3.3-specific polyclonal rabbit Ab. The average
Ct-value was determined from triplicate reactions and normalized with standard curves for each primer pair (Table 2). The y-axis indicates the
percentage of immunoprecipitated signal from the input (=100%). Values above 1% of input (dotted line) indicate chromatin/protein binding. The
term ‘% of input’ is commonly used as y-axis label for ChIP assays and reflects the percentage of signal normalized to the original sample prior to
IP. Values between 0% and 0.05% reflect no binding to promoter sequences. (C) Hepa RG cells were infected with H5pg4100 Ad5 wild-type at moi
of 5 and 100 FFU/cell. Then, 24 h p.i. cells were harvested and total cell extracts were prepared. Proteins were separated by SDS–PAGE and
subjected to immunoblotting using Daxx rabbit polyclonal antibody 07–471, ATRX-specific mouse MAb clone 39F, mouse E1B-55K-specific mouse
Mab 2A6 and ß-actin mouse MAb AC-15 as a loading control.
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degradation (Hep par; 100 FFU/cell) also results in loss of
H3.3 deposition on viral DNA. To gain further insight
into the ability of Ad to modulate chromatin structure,
we performed MNase chromatin sensitivity assays to
directly evaluate any consequence of proteasomal Daxx/
ATRX reduction due to E1B-55K and E4orf6 expression
on bulk cellular chromatin. We analysed MNase sensitiv-
ity of chromatin from Ad-infected HepaRG parental
(100 FFU/cell), uninfected HepaRG parental and
shDaxx cells (Figure 9) and observed that Daxx reduction
in Hep shDaxx and Hep parental (100 FFU/cell) resulted
in a greater sensitivity of the chromatin to MNase diges-
tion compared with uninfected control cells (Hep parental
mock). This is evident from the increase in mono-, di- and
tri-nucleosomes after equivalent lengths of MNase treat-
ment (1, 2, 5 and 7.5min; Figure 9) and by the reduced
amount of undigested chromatin in the absence of Daxx
(Hep shDaxx mock and Hep parental, 100 FFU/cell). In
contrast to this, presence of Daxx (Hep parental mock)
promoted reduced sensitivity of the chromatin to MNase
digestion (Figure 9). Therefore, it is likely that Daxx re-
duction by either siRNA-mediated techniques or product-
ive Ad5 infection results in a less condensed and accessible
chromatin architecture. These findings demonstrate that
functional Daxx/ATRX cooperation is important for
chromatin remodelling, and depletion of these cellular
factors results in a less condensed chromatin state and
enhanced viral gene expression.
DISCUSSION
Chromatin structure is regulated by multiprotein
complexes that either covalently modify histone tails or
remodel nucleosomes in an ATP-dependent manner (73).
Together, these complexes cooperate to dynamically
regulate chromatin structure. To date, considerable
progress has been made in studying ATP-dependent chro-
matin remodelling complexes, mediating essential steps in
regulating eukaryotic gene expression. These chromatin-
associated complexes are highly conserved during evolu-
tion and often recruited to targets by sequence-specific
transcription factors binding to certain promoters (74).
SWI/SNF complexes use the energy of ATP-hydrolysis
to alter histone/DNA contacts, leading to changes in chro-
matin conformation depending on acetylation of the
N-terminal core histone tails (see Figure 6B). Although
the basic mechanism is still not fully understood, obvi-
ously DNA viruses have acquired various strategies to
interfere with chromatin remodelling, modulate histone/
DNA contacts and establish lytic or latent infection.
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Figure 9. MNase nuclease accesibility assay to monitor Daxx/ATRX-mediated modulation of chromatin structure. Hepa RG cells were either
untreated or infected with H5pg4100 Ad5 wild-type at moi of 100 FFU/cell for 24 h. Chromatin sensitivity assays were performed using digestion
with 20 U of MNase for the indicated periods followed by an RNase treatment. Digested chromatin was analysed on a 1.4% agarose gel using the
G-Box system and Gene-Tools software (Syngene). Band intesities were quantified with ImageJ and analysed with GraphPad Prism software. Mono-,
di-, tri and poly-nucleosomes are indicated on the right.
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Figure 10. Model for Ad5-mediated restriction of cellular Daxx/ATRX chromatin remodelling complexes. (A) A schematic representation of known
cellular Daxx localizations in human cells. Nuclear Daxx is associated with either PML-NBs or ATRX at heterochromatin foci. Daxx ability to
repress transcription is inhibited by its localization to the PML-NB (82). Cytoplasmic Daxx has been reported to be involved in cell death (56,83). (B)
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repressive Daxx/ATRX complex from the viral genome, relieving negative regulation of Ad transcription.
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Ad viruses infect a wide range of cell types,
promoting cell cycle progression and simultaneously
blocking apoptosis and growth arrest (23,75–77). Con-
sequently, manipulation of host cell homeostasis is
required for Ad productive infection. Considering the fun-
damental importance of chromatin formation in
regulating gene expression in host cells, it remains
unclear whether Ad DNA is chromatinized and whether
Ad transcription is regulated by cellular chromatin
remodelling complexes.
However, recent findings illustrate that Ad genomes
are highly condensed by viral core proteins in the capsid
(78–80). This core/DNA complex enters the host cell
nucleus and decondenses before early viral gene transcrip-
tion (72). Although the molecular details are still unclear,
dynamic regulation of chromatin condensation suggests
involvement of cellular chromatin remodelling complexes.
Our findings illustrate that cellular Daxx/ATRX chroma-
tin remodelling complexes associate with Ad genomes and
promotes active viral gene transcription during the imme-
diate early phase of Ad infection (Figure 3B).
Daxx is reportedly involved in depositing cellular
histone variant H3.3 on actively transcribed genes
(19,20,70). In line with this, Ad DNA was recently
observed to preferentially associate with H3.3 (71),
indicating that chromatinization by a replication-
independent mechanism may play a so far unknown role
during the Ad life cycle. Interestingly, H3.3 was also found
to be complexed with ‘herpes simplex virus type 1’ DNA
during the early phase of infection (81). Altogether, H3.3
deposition on incoming genomes of DNA viruses suggests
a common mechanism for histone deposition in
promoting efficient viral gene expression (71,81). Daxx’s
impact on chromatinization via H3.3 deposition is consist-
ent with our findings of functional Daxx-ATRX cooper-
ation within a SWI/SNF chromatin remodelling complex
(Figure 9, summarized in Figure 10).
Recent results together with our observations demon-
strate the importance of a functional interplay between
two types of Daxx chromatin remodelling activities on
efficient Ad gene expression. As it is speculated that Ad
DNA is chromatinized, epigenetic regulation may be as
important for expression of Ad-encoded genes as for ex-
pression of host cell genes. Komatsu et al. (72) showed an
increase over time in acetylated H3 association at all Ad
promoters tested.
In agreement, we show here that Ad promoters are
affected by Daxx/ATRX-mediated transcriptional repres-
sion. As acetylated histones are associated with actively
transcribed genes, this suggests that inhibiting Daxx/
ATRX recruitment of HDAC to these promoters
changes the epigenetic status for optimal viral gene expres-
sion. Thus, E1B-55K/E4orf6-dependent restriction of
Daxx/ATRX functional complexes may be relevant for
the virus to evade antiviral host cell measures to repress
viral gene expression. Indeed, recent reports demonstrate
that during Ad vector studies, viral chromatin was prefer-
entially associated with deacetylated histones, markers of
transcriptionally inactive chromatin (71,84). These obser-
vations clearly illustrate the importance of epigenetic regu-
lation of Ad DNA at the chromatin level by expressing
early viral proteins that counteract chromatin remodelling
functions of the cell.
To ensure efficient viral gene expression, it seems
reasonable that Daxx and ATRX are eliminated during
Ad5 infection, or their repressive capacity is limited
by E1B-55K interaction, Daxx/ATRX protein degrad-
ation, or induction of posttranslational modifications.
However, our findings illustrate that Ad5-mediated
degradation discriminates between E1B-55K- (Daxx)
and E1B-55K/E4orf6 (ATRX)-dependent pathways.
Nevertheless, it is still unclear how and why Ad5 differen-
tially regulates Daxx and ATRX proteolysis.
Furthermore, it remains elusive whether the proposed
mechanism is a kinetic process owing to expression or
post-translational modification of viral proteins E1B-
55K and E4orf6 early during Ad5 infection.
Chromatin modifying complexes have also been
implicated in human cancer development. There is
growing evidence for a correlation between chromatin
modifiers and tumour suppression, especially demonstrated
for SWI/SNF complexes, which comprise several subunits
displaying tumour suppressor activity (73). Functional dis-
ruption of SWI/SNF complexes may induce a state of epi-
genetic instability, resulting in altered chromatin structure
that affects gene expression and interferes with differenti-
ation processes. These epigenetic changes may be closely
linked to genomic instability and predispose to oncogenic
transformation. In this context, our recent studies already
provide evidence that efficient adenoviral transformation
requires E1B-55K-mediated degradation of Daxx (61). In
accordance to our current study, we assume that this Ad
oncoprotein contributes to cell transformation by
modulating Daxx-dependent pathways and consequently
through disrupting SWI/SNF chromatin remodelling func-
tions. This is a particularly interesting concept, given the
oncogenic capabilities of certain adenoviral oncogenes (e.g.
E1A, E1B-55K, E4orf6), which we have partially shown to
cooperate with either Daxx and/or ATRX. Therefore,
elucidating the mechanisms of these cellular regulators, as
subunits of cellular SWI/SNF complexes, will help to define
the role of chromatin remodelling in both Ad5 transcrip-
tional regulation and adenoviral transformation of primary
cells. These findings might also help to identify novel thera-
peutic approaches to modern cancer therapy.
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